Skip to content

Addiction: all studies

Page 748 of 857: studies 7,471 to 7,480 of 8,563, newest first. Back to the addiction overview

Research

Resting-State Functional Connectivity Reflects Structural Connectivity in the Default Mode Network

Cerebral Cortex April 9, 2008 Michael D. Greicius, Kaustubh Supekar, V. Menon et al. 2,227 citations

Resting-state functional connectivity magnetic resonance imaging (fcMRI) studies constitute a growing proportion of functional brain imaging publications. This approach detects temporal correlations in spontaneous blood oxygen level-dependent (BOLD) signal oscillations while subjects rest quietly in the scanner. Although distinct resting-state networks related to vision, language, executive...

MDMA modifies active avoidance learning and recall in mice.

Psychopharmacology April 2008 José Manuel Trigo, Araceli Cabrero-Castel, Fernando Berrendero et al.

Several studies have suggested the existence of cognitive deficits after repeated or high doses of 3,4-methylenedioxymethamphetamine (MDMA) in humans and experimental animals. However, the extent of the impairments observed in learning or memory tasks remains unclear. The objective of this study was to evaluate the effects of different dosing regimens of MDMA on the ability of mice to learn and...

2C‐T‐4 intoxication: Acute psychosis caused by a designer drug

Psychiatry and Clinical Neurosciences April 1, 2008 Miho Miyajima, Toshihiko Matsumoto, Shigeo Ito 45 citations

DESIGNER DRUG ABUSE is a serious problem in Japan.1 Recently we encountered an acute intoxication in an emergency setting involving one such drug, which has never been reported as a clinical case anywhere. A 40-year-old man, with no previous history of mental disorder, although having had experiences of occasional use of street drugs, was brought to the emergency room by his mother. He was in a...

d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.

European Journal of Pharmacology March 31, 2008 Chad J Reissig, Richard A. Rabin, Jerrold C Winter et al.

Induction of mRNA or protein for immediate-early genes, such as c-fos, is used to identify brain areas, specific cell types, and neuronal circuits that become activated in response to various stimuli including psychoactive drugs. The objective of the present study was to identify the cell types in the prefrontal cortex in which lysergic acid diethylamide (d-LSD) induces c-Fos expression....

Brain Circuits for Consciousness

Brain, Behavior and Evolution March 28, 2008 Stuart J. Dimond

The question is explored of the location of consciousness in the human brain. The author''s own studies of defects of consciousness as the result of the splitting of the corpus callosum are described and disorders of consciousness associated with damage to other specific areas of the brain are reviewed. A circuit spanning the brain is described which stretches from the parietal lobe at one side...

Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.

Journal of Medicinal Chemistry March 27, 2008 Brian E. Kane, Christopher R Mccurdy, David M Ferguson

The structural basis to salvinorin A recognition of the kappa-opioid receptor is evaluated using a combination of site-directed mutagenesis and molecular-modeling techniques. The results show that salvinorin A recognizes a collection of residues in transmembrane II and VII, including Q115, Y119, Y313, I316, and Y320. The mutation of one hydrophobic residue in particular, I316, was found to...

Journey through the K-hole: phenomenological aspects of ketamine use.

Drug and Alcohol Dependence March 19, 2008 L Muetzelfeldt, Sunjeev K. Kamboj, H Rees et al.

Although recreational use of the dissociative anaesthetic drug ketamine is currently increasing, little is known about the phenomenological aspects of its use. We therefore designed a structured interview to examine initiation experiences, positive and negative effects of ketamine use, and concerns about the drug and its long-term effects. Ninety participants (30 frequent users, 30 infrequent...

DOI: 10.1016/j.drugalcdep.2008.01.024 (opens in new tab) Ketamine Humans Substance-related disorders Attitude +6

Serotonin 5-HT2BReceptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT ReleaseIn VivoandIn Vitro

Journal of Neuroscience March 12, 2008 Stéphane Doly, Emmanuel Valjent, Vincent Setola et al. 140 citations

The “club drug” 3,4-methylenedioxymethamphetamine (MDMA; also known as ecstasy) binds preferentially to and reverses the activity of the serotonin transporter, causing release of serotonin [5-hydroxytryptamine (5-HT)] stores from nerve terminals. Subsequent activation of postsynaptic 5-HT receptors by released 5-HT has been shown to be critical for the unique psychostimulatory effects of MDMA....

Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.

Neuroscience March 3, 2008 A R Alvaro, J Martins, A C Costa et al.

Ecstasy (3,4-methylenedioxymethamphetamine; MDMA) has potent CNS stimulant effects. Besides the acute effects of MDMA, such as psychomotor activation, euphoria, decreased appetite, and hyperthermia, long-term damage of dopaminergic and serotonergic nerve terminals in multiple brain areas have also been reported. Although some studies have demonstrated that considerable amounts of MDMA reach the...

2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.

Journal of Pharmacology and Experimental Therapeutics March 2008 Yulin Wang, Yong Chen, Wei Xu et al.

Salvinorin (Sal) A is a naturally occurring, selective kappa opioid receptor (KOPR) agonist with a short duration of action in vivo. Pharmacological properties of a C(2) derivative, 2-methoxymethyl (MOM)-Sal B, were characterized. MOM-Sal B bound to KOPR with high selectivity and displayed approximately 3-fold higher affinity than U50,488H...